A Study of (14C)-JNJ-73841937 (Lazertinib) in Healthy Male Participants
Clinical trial NCT04410081 · COMPLETED
Trial details
- NCT number
- NCT04410081
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2021-03-02
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.